Rafferty Asset Management’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
Rafferty Asset Management's ORKA Position: Q3 2026 in Review
Rafferty Asset Management increased its Oruka Therapeutics (ORKA) stake by 62% in Q3 2026, buying an estimated $2.52M and bringing the position to 69,824 shares worth $5.82M. The position accounts for 0.02% of the portfolio, ranked #351.
Rafferty Asset Management first reported a position in ORKA in Q3 2025 and has held it in 5 quarters since. 175 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- Rafferty Asset Management held 69,824 shares of Oruka Therapeutics worth $5.82M as of Q3 2026.
- Rafferty Asset Management bought 26,714 Oruka Therapeutics shares in Q3 2026, an estimated $2.52M.
- Oruka Therapeutics made up 0.02% of Rafferty Asset Management's portfolio in Q3 2026, its #351 holding.
- Rafferty Asset Management first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 175 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.